Cover Image

Severe Atopic Dermatitis In Spain: A Real-Life Observational Study

Antoni Sicras-Mainar,1 Ruth Navarro-Artieda,2 José C Armario-Hita3 1Scientific Direction, Real Life Data, Madrid, Spain; 2Medical Documentation, Germans Trias i Pujol Hospital, Barcelona, Spain; 3Dermatology Service, Puerto Real University Hospital, Cadiz University, Cádiz, Spa...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sicras-Mainar A (Author), Navarro-Artieda R (Author), Armario-Hita JC (Author)
Format:	Book
Published:	Dove Medical Press, 2019-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

[Translated article] Patient-Reported Outcome Measures in Real-World Atopic Dermatitis Studies in Spain: A Systematic Review
by: J.C. Armario-Hita, et al.
Published: (2022)

Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain
by: E. Artime, et al.
Published: (2023)

104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain,
by: Jose Juan Pereyra-Rodriguez, et al.
Published: (2022)

Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey
by: Joaquín Sastre, et al.
Published: (2020)

Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
by: Sicras-Mainar A, et al.
Published: (2015)

Impact on healthcare resource utilization of multiple sclerosis in Spain
by: Antoni Sicras-Mainar, et al.
Published: (2017)

Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly
by: Sicras-Mainar A, et al.
Published: (2014)

Validación retrospectiva del Johns-Hopkins ACG Case-Mix System en la población Española Validating the Adjusted Clinical Groups [ACG] Case-mix System in a Spanish population setting: a multicenter study
by: Antoni Sicras-Mainar, et al.
Published: (2009)

Influencia de la sustitución de medicamentos de marca por genéricos en el cumplimiento terapéutico de la hipertensión arterial y la dislipidemia Influence of substitution of brand name for generic drugs on therapeutic compliance in hypertension and dyslipidemia
by: Antoni Sicras Mainar, et al.
Published: (2010)

Real‐life case‐series experience with tralokinumab in patients with severe atopic dermatitis
by: Francesca Caroppo, et al.
Published: (2024)

Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
by: Danielle Rogner, et al.
Published: (2022)

Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus
by: Jose J. Pereyra-Rodriguez, et al.
Published: (2023)

Severe and ChRonic Atopic dermatitis Treatment CoHort (SCRATCH): A Danish Real-world Evidence Atopic Dermatitis Treatment Registry
by: Henrik Hedegaard Pliess Larsen, et al.
Published: (2022)

Assessment of the severity of atopic dermatitis
by: Agnieszka Bożek, et al.
Published: (2016)

Treatment profiles and costs of patients with chronic pain in the population setting
by: Sicras Mainar A, et al.
Published: (2012)

Impacto de la morbilidad, uso de recursos y costes en el mantenimiento de la remisión de la depresión mayor en España: estudio longitudinal de ámbito poblacional Impact of morbidity, resource use and costs on maintenance of remission of major depression in Spain: a longitudinal study in a population setting
by: Antoni Sicras-Mainar, et al.
Published: (2010)

Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience
by: Luigi Gargiulo, et al.
Published: (2023)

Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
by: Francesca Barei, et al.
Published: (2024)

Optimization of approaches to the management of adult patients with severe atopic dermatitis: analysis of real clinical practice outcomes
by: Daria S. Fomina, et al.
Published: (2021)

Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study
by: Teppei Hagino, et al.
Published: (2024)

Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience
by: Luigi Gargiulo, et al.
Published: (2023)

A Real-Life Based Evaluation of the Effectiveness of Antibacterial Fabrics in Treating Atopic Dermatitis
by: Dirk Höfer
Published: (2018)

Atopic dermatitis in 32 children treated with dupilumab in real life. A new contribution
by: Isabel Betlloch‐Mas, et al.
Published: (2024)

CYCLOSPORINE IN TREATMENT OF SEVERE ATOPIC DERMATITIS IN CHILDREN
by: A.A. Alekseeva
Published: (2010)

CYCLOSPORINE IN TREATMENT OF SEVERE ATOPIC DERMATITIS IN CHILDREN
by: A.A. Alekseeva
Published: (2010)

Cost and clinical consequences of smoking cessation in outpatients after cardiovascular disease: a retrospective cohort study
by: Sicras-Mainar A, et al.
Published: (2013)

Labial Melanotic Macules in Atopic Dermatitis: An Observational Study
by: Mohammed I Aljasser, et al.
Published: (2019)

Real‐world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2‐year experience
by: Chisako Fujiwara, et al.
Published: (2023)

Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review
by: Ibba L, et al.
Published: (2024)

Effects of disease severity on sleep and quality of life in Taiwanese patients with atopic dermatitis
by: Pei-Yun Ho, MD, et al.
Published: (2022)

Efficacy of dupilumab in moderate and severe atopic dermatitis
by: Stephan Weidinger, et al.
Published: (2023)

Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series
by: Patrícia Amoedo, et al.
Published: (2024)

[Translated article] Efficacy and Pharmacoeconomic Analysis in Real Clinical Practice Conditions of Patients with Plaque Psoriasis Treated with Guselkumab: A Retrospective Multicenter Study
by: R. Ruiz-Villaverde, et al.
Published: (2024)

Relationship Between Concomitant Atopic Diseases With Atopic Dermatitis Severity And Persistence.
by: Adawiyah Jamil, et al.
Published: (2021)

Management of severe atopic dermatitis in adult patients
by: Aleksandra Kobusiewicz, et al.
Published: (2020)

Preliminary experience with abrocitinib in severe atopic dermatitis
by: Silvia Ferrucci, et al.
Published: (2024)

Secukinumab: supervivencia en práctica clínica real
by: R. Ruiz-Villaverde, et al.
Published: (2021)

Posibilidades de los Grupos Clínicos Ajustados (Ajusted Clinical Groups-ACGs) en el ajuste de riesgos de pago capitativo
by: Antoni Sicras-Mainar, et al.
Published: (2006)

Medidas de los resultados percibidos por el paciente en estudios de vida real en dermatitis atópica en España: revisión sistemática de la literatura
by: J.C. Armario-Hita, et al.
Published: (2022)

Observational 24‐week study to assess clinical response to upadacitinib posttrial in patients with moderate‐to‐severe atopic dermatitis
by: Ana Batalla, et al.
Published: (2023)